U.S. patient preferences for long-acting HIV treatment: a discrete choice experiment.

ABSTRACT:

Introduction

Recent advances in long-acting antiretroviral therapy (LA-ART) could provide new options for HIV treatment and reduce adherence barriers, if regimens are acceptable to patients. We elicited preferences for key attributes of potential LA-ART regimens among people with HIV (PWH) in the United States, focusing on four treatment modes (oral tablets, subcutaneous injections, intramuscular injections, and implants), product characteristics and location of administration.

Methods

A discrete choice experiment was conducted among PWH aged ≥18 years recruited from HIV clinics in Washington State and Atlanta, Georgia from March 2021 to June 2022. Participants responded to 17 choice scenarios, each with three options: two systematically generated hypothetical LA-ART regimen

SUBMITTER: Graham SM 

PROVIDER: S-EPMC10338996 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature